Author
University of HelsinkiORCID 0000-0001-6353-0664Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
5 papers
Recent·Most cited
Elham Gholizadeh, Uladzislau Vadadokhau, Mücahit Varlı…·Mohieddin Jafari
This study uses CoPISA and proteomics to analyze venetoclax-azacitidine response in AML cells, identifying adaptive vulnerabilities like NRP2.
Sadiksha Adhikari, Philipp Sergeev, Nemo Ikonen…·Caroline Akemi Heckman
This study uses scRNA-seq to analyze AML patient samples across disease stages, identifying immune dysregulation and potential therapeutic targets.
Elham Gholizadeh, Ehsan Zangene, Alun Parsons…·Mohieddin Jafari
This study evaluates two drug combinations for AML treatment, showing improved efficacy over venetoclax-based therapy in specific mutation profiles.
Aleksandr Ianevski, Kristen Michelle Nader, Kyriaki Driva…·Tero A. Aittokallio
The paper develops a machine learning model to identify patient-specific multi-targeting therapies using single-cell transcriptomic data for hematological cancers and solid tumors.
Aleksandr Ianevski, Jenni Lahtela, Komal Kumar Javarappa…·Tero A. Aittokallio
This paper develops a computational-experimental approach to design patient-specific drug combinations for AML that are synergistic and minimally toxic.